| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > Let Globalisation Help You Invest in African Countries |
|
Write You - Let Globalisation Help You Invest in African Countries
Why Africa? Many more companies are being brought to the stock market in Africa and ev According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product en though their profits can not be compared to their western counterparts many brokers ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in re making a killing with these initial share offers. Shares in African Stock markets ar lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. also cheap and therefore anyone willing to invest in African stocks can do so. Case S here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe tudy A recent public share offer of a Kenyan company "Kengen". On its first day on the d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro stock market Kengen the price of each share tripled with some shareholders selling thei ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc shares at a price six times the price they had bought their shares for. The kengen Sha easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi re offer in Kenya is just an example of the many opportunities Africa has to offer. Gl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically balization means unlimited Potential Most African countries are developing countries. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ his therefore means that manufacturing and industrial companies are being set up every ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi onth and consequently more and more companies in Africa are maturing and being brought ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a to the stock market to be traded. Shares in African stock markets fluctuate alot and ar dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod therefore attractive for someone hoping to make a quick killing. Tips on how to inves cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin in Africa If you are serious about investing in Africa I would suggest you get some t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen rustworthy contacts from an individual or even better an organization within the countr t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel you intend to invest in. That is if you do not reside or are not a resident in that co ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ntry. This is because it is very easy to be conned especially considering most Investme y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nt banks in africa or stock markets do not trade online. To cap it all Choose your brok . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r well. I think later i will write on tips for choosing an appropriate stock broker. © elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Best Business Card I Ever Saw
|